The panel discussing Parkinson’s Progression Marker Initiative at the MJFF’s Parkinson’s Disease Therapeutics Conference in New York. From implanting cells into the brain to prevent the loss of dopamine producing...

As federal regulators listened, patients told them of their symptoms – the sleepless nights, the days with uncontrollable tremors or the little struggles simply maintaining their balance. Paul Cannon, 23andMe’s...

At an annual conference last month sponsored by the Michael J. Fox Foundation, scientists, academics and business representatives gathered in New York City to explore some of the latest and...